John Rogers - Ariel Investments,
Holding/activity history for Cumberland Pharmaceuticals Inc (CPIX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2021 Q2 | 12,033 | <0.01 | Reduce 94.33% | <0.01 | $2.83 | $34,000 | SEC |
| 2021 Q1 | 212,370 | 0.01 | Reduce 74.14% | 0.02 | $3.03 | $643,000 | SEC |
| 2020 Q4 | 821,096 | 0.03 | Add 4.94% | <0.01 | $2.95 | $2,422,000 | SEC |
| 2020 Q3 | 782,441 | 0.04 | $3.21 | $2,512,000 | SEC | ||
| 2020 Q2 | 782,441 | 0.04 | Reduce 27.83% | 0.02 | $3.33 | $2,606,000 | SEC |
| 2020 Q1 | 1,084,223 | 0.07 | Add 7.33% | <0.01 | $3.63 | $3,936,000 | SEC |
| 2019 Q4 | 1,010,220 | 0.07 | Add 5.42% | <0.01 | $5.15 | $5,203,000 | SEC |
| 2019 Q3 | 958,319 | 0.08 | Reduce 25.20% | 0.03 | $5.93 | $5,683,000 | SEC |
| 2019 Q2 | 1,281,104 | 0.10 | Add 6.78% | <0.01 | $6.37 | $8,161,000 | SEC |
| 2019 Q1 | 1,199,707 | 0.09 | Add 1.69% | <0.01 | $5.81 | $6,970,000 | SEC |
| 2018 Q4 | 1,179,803 | 0.10 | Reduce 8.56% | <0.01 | $6.03 | $7,114,000 | SEC |
| 2018 Q3 | 1,290,317 | 0.08 | Reduce 1.13% | <0.01 | $5.71 | $7,368,000 | SEC |
| 2018 Q2 | 1,305,052 | 0.09 | Add 28.71% | 0.02 | $6.13 | $8,000,000 | SEC |
| 2018 Q1 | 1,013,926 | 0.08 | Add 11.41% | <0.01 | $6.68 | $6,773,000 | SEC |
| 2017 Q4 | 910,076 | 0.08 | Add 2.58% | <0.01 | $7.36 | $6,698,000 | SEC |
| 2017 Q3 | 887,144 | 0.07 | Reduce 9.14% | <0.01 | $7.06 | $6,263,000 | SEC |
| 2017 Q2 | 976,377 | 0.08 | Reduce 29.91% | 0.04 | $7.00 | $6,835,000 | SEC |
| 2017 Q1 | 1,393,125 | 0.12 | Reduce 23.65% | 0.03 | $6.94 | $9,668,000 | SEC |
| 2016 Q4 | 1,824,580 | 0.12 | Reduce 10.99% | 0.01 | $5.50 | $10,035,000 | SEC |
| 2016 Q3 | 2,049,760 | 0.13 | Add 2.87% | <0.01 | $5.01 | $10,269,000 | SEC |
| 2016 Q2 | 1,992,613 | 0.12 | Add 0.81% | <0.01 | $4.50 | $8,967,000 | SEC |
| 2016 Q1 | 1,976,671 | 0.11 | Add 39.53% | 0.03 | $4.49 | $8,875,000 | SEC |
| 2015 Q4 | 1,416,660 | 0.09 | Reduce 4.54% | <0.01 | $5.26 | $7,452,000 | SEC |
| 2015 Q3 | 1,484,096 | 0.11 | Reduce 1.39% | <0.01 | $5.77 | $8,563,000 | SEC |
| 2015 Q2 | 1,505,086 | 0.13 | Reduce 21.09% | 0.03 | $7.15 | $10,761,000 | SEC |
| 2015 Q1 | 1,907,242 | 0.16 | Reduce 8.54% | 0.01 | $6.66 | $12,702,000 | SEC |
| 2014 Q4 | 2,085,426 | 0.16 | Reduce 20.01% | 0.04 | $5.98 | $12,471,000 | SEC |
| 2014 Q3 | 2,607,251 | 0.18 | Reduce 2.10% | <0.01 | $4.94 | $12,880,000 | SEC |
| 2014 Q2 | 2,663,170 | 0.16 | Reduce 0.01% | $4.50 | $11,984,000 | SEC | |
| 2014 Q1 | 2,663,520 | 0.16 | Add 4.91% | <0.01 | $4.50 | $11,986,000 | SEC |
| 2013 Q4 | 2,538,760 | 0.18 | Add 44.33% | 0.06 | $5.11 | $12,973,000 | SEC |
| 2013 Q3 | 1,758,955 | 0.13 | Add 23.37% | 0.02 | $4.53 | $7,968,000 | SEC |
| 2013 Q2 | 1,425,705 | 0.14 | Add 165.48% | 0.09 | $5.11 | $7,285,000 | SEC |
| 2013 Q1 | 537,021 | 0.05 | Buy | 0.05 | $4.98 | $2,674,000 | SEC |